All In Biotech

Free tool

FAERS Monitor: Sorilux

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 022563 or its brand name (Sorilux, Calcipotriene). Reports on generic versions are filed under their own applications.

Reports

3,507

Serious

1,417

40% of reports

Hospitalization

491

Death reported

69

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective843
  • psoriasis736
  • diarrhoea216
  • arthralgia205
  • rash197
  • nausea190
  • pain189
  • pruritus184
  • off label use179
  • headache174
  • product use in unapproved indication159
  • fatigue150
  • therapeutic product effect incomplete146
  • psoriatic arthropathy139
  • product dose omission issue127

Reports by year received

View as table
YearReports
20046
200510
200612
200716
200831
200921
201024
20116
201229
201353
201455
2015136
2016149
2017173
2018185
2019247
2020230
2021230
2022223
2023947
2024256
2025265
2026203

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,050,652 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
psoriasisSignal73634.031.923,541
psoriatic arthropathySignal13920.617.52,570
therapeutic product effect incompleteSignal14612.310.51,511
product use in unapproved indicationSignal1593.83.3336
drug ineffectiveSignal8433.83.61,883
arthralgiaSignal2053.02.6269
pruritusSignal1842.92.5227
rashSignal1972.72.4215
product dose omission issueSignal1272.62.2124
diarrhoeaSignal2162.01.8112
pain1891.81.675
headache1741.71.447
nausea1901.41.326
off label use1791.21.18
fatigue1501.21.03

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.